Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Parecoxib Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Parecoxib Sodium, including repackagers and relabelers. The FDA regulates Parecoxib Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Parecoxib Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Parecoxib Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Parecoxib Sodium supplier is an individual or a company that provides Parecoxib Sodium active pharmaceutical ingredient (API) or Parecoxib Sodium finished formulations upon request. The Parecoxib Sodium suppliers may include Parecoxib Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Parecoxib Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Parecoxib Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Parecoxib Sodium active pharmaceutical ingredient (API) in detail. Different forms of Parecoxib Sodium DMFs exist exist since differing nations have different regulations, such as Parecoxib Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Parecoxib Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Parecoxib Sodium USDMF includes data on Parecoxib Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Parecoxib Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Parecoxib Sodium suppliers with USDMF on PharmaCompass.
A Parecoxib Sodium written confirmation (Parecoxib Sodium WC) is an official document issued by a regulatory agency to a Parecoxib Sodium manufacturer, verifying that the manufacturing facility of a Parecoxib Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Parecoxib Sodium APIs or Parecoxib Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Parecoxib Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Parecoxib Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Parecoxib Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Parecoxib Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Parecoxib Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Parecoxib Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Parecoxib Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Parecoxib Sodium suppliers with NDC on PharmaCompass.
Parecoxib Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Parecoxib Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Parecoxib Sodium GMP manufacturer or Parecoxib Sodium GMP API supplier for your needs.
A Parecoxib Sodium CoA (Certificate of Analysis) is a formal document that attests to Parecoxib Sodium's compliance with Parecoxib Sodium specifications and serves as a tool for batch-level quality control.
Parecoxib Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Parecoxib Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Parecoxib Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Parecoxib Sodium EP), Parecoxib Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Parecoxib Sodium USP).
LOOKING FOR A SUPPLIER?
